Showing results (331-340 of 440) with videos related to

Sort By:
Pageof 44
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitorsPing Chen, Derek Norris, Jagabandhu Das, et al.
Science Immunology|May 26, 2023
IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulationPeyton E Conrey, Lidiya Denu, Kaitlin C O'Boyle, et al.
Journal of Medicinal Chemistry|December 28, 2002
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonistNatesan Murugesan, Zhengxiang Gu, Steven Spergel, et al.
Circulation|September 21, 2014
Assessment of atherosclerosis in chronic granulomatous diseaseChristopher T Sibley, Tyra Estwick, Anna Zavodni, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology MeetingJonathan M Spergel, Seema S Aceves, Kara Kliewer, et al.
Bioorganic & Medicinal Chemistry Letters|November 20, 2010
Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritisAlaric J Dyckman, Charles M Langevine, Claude Quesnelle, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2014
Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseasesQing Shi, Andrew Tebben, Alaric J Dyckman, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 2, 2022
CD73<sup>+</sup> Epithelial Progenitor Cells That Contribute to Homeostasis and Renewal Are Depleted in Eosinophilic EsophagitisTakeo Hara, Yuta Kasagi, Joshua Wang, et al.
The Lancet. Gastroenterology & Hepatology|June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trialNirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2018
Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic ReviewChristopher Ma, Bram D van Rhijn, Vipul Jairath, et al.
Pageof 44